- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Jan 31, 2025
594065202M122597.7VAMEDIU MIDDLEBROOK 7H11 + OFLOXACIN 2 µg/ml 7ml is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class A. Manufactured by SC MEDICAMED MARKET SRL. Placed on the EU market in Romania. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
05940652023642M122597.7(01)05940652023642
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0104010299MEDIA IN TUBES - OTHERRO-MF-000002243The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
Primary placement in Romania; available across 1 country total.
Placed on the market in Romania; per-country availability dates not published.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →No certificate specifically references this device's Basic UDI-DI.
594065202M122567.7UMOn the marketMEDIU MIDDLEBROOK 7H11 + ISONIAZIDE 1 µg/ml 7ml594065202M122577.7UUOn the marketMEDIU MIDDLEBROOK 7H11 + KANAMYCIN 6 µg/ml 7ml594065202M122587.7V3On the marketMEDIU MIDDLEBROOK 7H11 + PAS 8 µg/ml 7ml594065202M122607.7TNOn the marketMEDIU MIDDLEBROOK 7H11 + PYRAZINAMIDE 25 µg/ml 7ml594065202M122617.7TVOn the marketMEDIU MIDDLEBROOK 7H11 + RIFABUTIN 0.5 µg/ml 7ml594065202M122627.7U4On the marketNo certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.